Format

Send to

Choose Destination
Neurologia. 2015 Nov-Dec;30(9):536-44. doi: 10.1016/j.nrl.2014.06.002. Epub 2014 Jul 25.

Use of healthcare resources and costs of acute cardioembolic stroke management in the Region of Madrid: The CODICE Study.

[Article in English, Spanish]

Author information

1
Pharmacoeconomics and Outcomes Research Iberia (PORIB), Pozuelo de Alarcón, Madrid, España. Electronic address: fdeandres@porib.com.
2
Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria La Princesa, Madrid, España.
3
Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, España.
4
Hospital General Universitario Gregorio Marañón, Madrid, España.
5
Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, España.
6
Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Madrid, España.
7
Pharmacoeconomics and Outcomes Research Iberia (PORIB), Pozuelo de Alarcón, Madrid, España.
8
Departamento de Investigación de Resultados en Salud y Farmacoeconomía, Pfizer S. L. U., Alcobendas, Madrid, España.

Abstract

INTRODUCTION:

Stroke is the main cause of admission to Neurology departments and cardioembolic stroke (CS) is one of the most common subtypes of stroke.

METHODS:

A multicentre prospective observational study was performed in 5 Neurology departments in public hospitals in the Region of Madrid (Spain). The objective was to estimate the use of healthcare resources and costs of acute CS management. Patients with acute CS at<48h from onset were recruited. Patients' socio-demographic, clinical, and healthcare resource use data were collected during hospitalisation and at discharge up to 30 days after admission, including data for rehabilitation treatment after discharge.

RESULTS:

During an 8-month recruitment period, 128 patients were recruited: mean age, 75.3±11.25; 46.9% women; mortality rate, 4.7%. All patients met the CS diagnostic criteria established by GEENCV-SEN, based on medical history or diagnostic tests. Fifty per cent of the patients had a history of atrial fibrillation and 18.8% presented other major cardioembolic sources. Non-valvular atrial fibrillation was the most frequent cause of CS (33.6%). Data for healthcare resource use, given a mean total hospital stay of 10.3±9.3 days, are as follows: rehabilitation therapy during hospital stay (46.9%, mean 4.5 days) and after discharge (56.3%, mean 26.8 days), complications (32%), specific interventions (19.5%), and laboratory and diagnostic tests (100%). Head CT (98.4%), duplex ultrasound of supra-aortic trunks (87.5%), and electrocardiogram (85.9%) were the most frequently performed diagnostic procedures. Average total cost per patient during acute-phase management and rehabilitation was €13,139. Hospital stay (45.0%) and rehabilitation at discharge (29.2%) accounted for the largest part of resources used.

CONCLUSIONS:

Acute CS management in the Region of Madrid resulted consumes large amounts of resources (€13,139), mainly due to hospital stays and rehabilitation.

KEYWORDS:

Cardioembolic stroke; Comunidad de Madrid; Costes; Costs; Ictus; Infarto cerebral cardioembólico; Region of Madrid (Spain); Resource use; Sanidad Pública; Spanish National Health System; Stroke; Utilización de recursos

PMID:
25066492
DOI:
10.1016/j.nrl.2014.06.002
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Ediciones Doyma, S.L.
Loading ...
Support Center